These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12401157)

  • 1. Effectiveness of sibutramine.
    Lieberman JA
    J Fam Pract; 2002 Oct; 51(10):863; author reply 863, 867. PubMed ID: 12401157
    [No Abstract]   [Full Text] [Related]  

  • 2. Sibutramine in the management of obesity.
    Brunton S
    J Fam Pract; 2003 Aug; 52(8):635. PubMed ID: 12899819
    [No Abstract]   [Full Text] [Related]  

  • 3. Sibutramine for obesity.
    Med Lett Drugs Ther; 1998 Mar; 40(1022):32. PubMed ID: 9529518
    [No Abstract]   [Full Text] [Related]  

  • 4. Sibutramine in pregnancy.
    Ramzi F; Elias D; Mona S; Zreik TG
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):243-4. PubMed ID: 16219525
    [No Abstract]   [Full Text] [Related]  

  • 5. Sibutramine: an Australian analysis of reported adverse effects.
    Prescrire Int; 2007 Jun; 16(89):114. PubMed ID: 17590911
    [No Abstract]   [Full Text] [Related]  

  • 6. Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?
    von Haehling S; Lainscak M; Anker SD
    Eur Heart J; 2007 Dec; 28(23):2830-1. PubMed ID: 17984134
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of sibutramine therapy on occurrence of depression symptoms among obese patients.
    Slovacek L; Pavlik V; Slovackova B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):e43-4. PubMed ID: 18676135
    [No Abstract]   [Full Text] [Related]  

  • 8. Sibutramine and blood pressure: a therapeutic dilemma.
    Bray GA
    J Hum Hypertens; 2002 Jan; 16(1):1-3. PubMed ID: 11840223
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.
    Georgopoulos NA; Katsikis I; Florakis D; Panidis D; Kandarakis ED
    Fertil Steril; 2009 Jun; 91(6):e1. PubMed ID: 19362719
    [No Abstract]   [Full Text] [Related]  

  • 10. European Medicines Agency withdrawal for sibutramine.
    Galhardo J; Davis N; Matthai S; Shield JP
    Arch Dis Child; 2010 Oct; 95(10):856. PubMed ID: 20573736
    [No Abstract]   [Full Text] [Related]  

  • 11. Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias.
    Wooltorton E
    CMAJ; 2002 May; 166(10):1307-8. PubMed ID: 12041851
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention and management of obesity: pharmacology .
    Finer N
    Proc Nutr Soc; 2000 Aug; 59(3):413. PubMed ID: 10997657
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of obesity in practice - more necessary than ever].
    Wirth A
    Dtsch Med Wochenschr; 2002 Mar; 127(12):605. PubMed ID: 11907861
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug therapy for obesity: clarifications.
    Seaton TB
    J Am Pharm Assoc (Wash); 1997; NS37(4):374. PubMed ID: 9519642
    [No Abstract]   [Full Text] [Related]  

  • 15. [Back at the starting point. Obesity patients the losers when sibutramine (Reductil) is recalled].
    Rössner S
    Lakartidningen; 2010 Feb 3-9; 107(5):269. PubMed ID: 20297569
    [No Abstract]   [Full Text] [Related]  

  • 16. New obesity drug approved.
    Nurse Pract; 1998 Jan; 23(1):94, 99. PubMed ID: 9470201
    [No Abstract]   [Full Text] [Related]  

  • 17. Sibutramine-associated adverse effects: a practical guide for its safe use.
    Florentin M; Liberopoulos EN; Elisaf MS
    Obes Rev; 2008 Jul; 9(4):378-87. PubMed ID: 18034790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss can be as simple as 10, 20, 30--Knoll launches blueprint for the use of sibutramine in weight management.
    Cardiovasc J S Afr; 2001; 12(5):286-7. PubMed ID: 11924520
    [No Abstract]   [Full Text] [Related]  

  • 19. [Abuse potential of sibutramine].
    Saiz Ruiz J; Saiz González D; Antón Fructuoso P
    Med Clin (Barc); 2003 May; 120(16):639. PubMed ID: 12732133
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment.
    O'Meara S; Riemsma R; Shirran L; Mather L; ter Riet G
    Health Technol Assess; 2002; 6(6):1-97. PubMed ID: 12000688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.